Pu, Congying
Cui, Hui
Yu, Huaxing
Cheng, Xin
Zhang, Man
Qin, Luoheng
Ning, Zhilin
Zhang, Wen
Chen, Shan
Qian, Yuhang
Wang, Feng
Wang, Ling
Lin, Xiaoxia
Gennert, David
Pun, Frank W. https://orcid.org/0000-0001-8801-6645
Ren, Feng https://orcid.org/0000-0001-9157-9182
Zhavoronkov, Alex https://orcid.org/0000-0001-7067-8966
Article History
Received: 28 August 2024
Accepted: 7 May 2025
First Online: 23 May 2025
Competing interests
: The Authors declare the following competing interests: All listed authors are affiliated with Insilico Medicine, a global clinical-stage commercial generative AI company with several hundred patents and patent applications and commercially available software. Insilico Medicine is a company developing an AI-based end-to-end integrated pipeline for drug discovery and development that is engaged in drug-discovery programs for aging, fibrosis and oncology. C.P., H.C., H.Y., X.C., M.Z., L.Q., Z.N., W.Z., S.C., L.W., X.L., D.G., F.W.P., F.R., and A.Z. are affiliated with Insilico Medicine or were affiliated with Insilico Medicine when the studies were performed. The remaining authors declare no competing interest. No other conflicts are reported.